Then, we extracted the proteins from subcutaneously transplanted tumours and conducted western blotting experiments, which also confirmed reduced FOXM1, STAT3, p-STAT3 and GPX4 expression in subcutaneous tumours from the TST treatment group (Fig. 5E, F). The gene discussed is GPX4; the disease is neoplasm.